Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
The frequencies distribution of CYP3A5 rs776746 and ABCB1 rs1045642 polymorphisms in the west Algerian population and relationships with pharmacogeneticsAmmour, Amina ; Aberkane, Meriem ; Boudjema, Abdallah ; Boughrara, Wefa ; Mediene Benchekor, SounniaAfrican health sciences, 2024-03, Vol.24 (1), p.307-312 [Periódico revisado por pares]Kampala, Uganda: Makerere Medical SchoolTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Correlation between CYP3A5 gene polymorphism and BK virus infection in kidney transplant recipientsGuo, Jiayu ; Yu, Bo ; Zou, Jilin ; Zhang, Long ; Wang, Tianyu ; Zhou, Jiangqiao ; Qiu, TaoTransplant immunology, 2022-12, Vol.75, p.101709-101709, Article 101709 [Periódico revisado por pares]Elsevier B.VTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantationRao, Nikhil ; Carcella, Taylor ; Patel, Neha ; Bartlett, Felicia ; Posadas, Maria Aurora ; Casey, Michael ; Dubay, Derek A ; Taber, David JPharmacogenetics and genomics, 2023-04, Vol.33 (3), p.59-65 [Periódico revisado por pares]United StatesTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Clinical determinants of calcineurin inhibitor disposition: a mechanistic reviewVanhove, Thomas ; Annaert, Pieter ; Kuypers, Dirk R. J.Drug metabolism reviews, 2016-01, Vol.48 (1), p.88-112 [Periódico revisado por pares]England: Taylor & FrancisTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
The impact of CYP3A5 3 polymorphism on sirolimus pharmacokinetics: insights from predictions with a physiologically‐based pharmacokinetic modelEmoto, Chie ; Fukuda, Tsuyoshi ; Venkatasubramanian, Raja ; Vinks, Alexander A.British journal of clinical pharmacology, 2015-12, Vol.80 (6), p.1438-1446 [Periódico revisado por pares]Texto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Strong influence of donor and recipient CYP3A5 genotype on tacrolimus disposition leading to difficult dose adjustment in a pediatric liver transplantationKauv, Juliette ; Laborde, Nolwenn ; Ackermann, Oanez ; Verstuyft, Céline ; Furlan, ValérieJournal of liver transplantation, 2022-10, Vol.8, p.100132, Article 100132 [Periódico revisado por pares]Elsevier Masson SASTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Tacrolimus dose, blood concentrations and acute nephrotoxicity, but not CYP3A5/ABCB1 genetics, are associated with allograft tacrolimus concentrations in renal transplant recipientsSallustio, Benedetta C. ; Noll, Benjamin D. ; Hu, Rong ; Barratt, Daniel T. ; Tuke, Jonathan ; Coller, Janet K. ; Russ, Graeme R. ; Somogyi, Andrew A.British journal of clinical pharmacology, 2021-10, Vol.87 (10), p.3901-3909 [Periódico revisado por pares]EnglandTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate CancerGorjala, Priyatham ; Kittles, Rick A ; Goodman, Jr, Oscar B ; Mitra, RanjanaCancers, 2020-04, Vol.12 (4), p.989 [Periódico revisado por pares]Switzerland: MDPITexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Association of CYP3A41B, CYP3A422 and CYP3A53 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasiaAbdullaev, Sh. P. ; Shatokhin, M. N. ; Sigailo, O. L. ; Abdullaev, Sh. P. ; Bochkov, P. O. ; Tuchkova, S. N. ; Teodorovich, O. V. ; Loran, O. B. ; Sychev, D. A.Farmaciâ i Farmakologiâ (Pâtigorsk), 2024-05, Vol.12 (1), p.32-48 [Periódico revisado por pares]Texto completo disponível |
10 |
Material Type: Artigo
|
![]() |
The importance of CYP2C19 genotype in tacrolimus dose optimization when concomitant with voriconazole in heart transplant recipientsHuang, Xiao ; Zhou, Ying ; Zhang, Jing ; Xiang, Hongping ; Mei, Hao ; Liu, Li ; Tong, Lu ; Zeng, Fang ; Huang, Yifei ; Zhou, Hong ; Zhang, YuBritish journal of clinical pharmacology, 2022-10, Vol.88 (10), p.4515-4525 [Periódico revisado por pares]EnglandTexto completo disponível |